PT  - JOURNAL ARTICLE
AU  - Turunen, R
AU  - Pulakka, A
AU  - Metsälä, J
AU  - Vahlberg, T
AU  - Ojala, T
AU  - Gissler, M
AU  - Kajantie, E
AU  - Helle, E
TI  - Maternal diabetes and overweight as risk factors for congenital heart defects in offspring - A nationwide register study from Finland
AID  - 10.1101/2023.02.14.23285825
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.14.23285825
4099  - http://medrxiv.org/content/early/2023/02/17/2023.02.14.23285825.short
4100  - http://medrxiv.org/content/early/2023/02/17/2023.02.14.23285825.full
AB  - Importance Congenital heart defects (CHDs) affect 1–2% of newborns and are associated with significant mortality and morbidity. Understanding risk factors underlying CHDs is essential for prevention.Objective To determine the association between maternal diabetes and overweight/obesity and CHDs among offspring.Design Nationwide population-based register study.Setting FinlandParticipants All children born between 2006–2016 (N=620 751), and their mothers.Exposures Maternal pre-pregnancy body mass index (BMI) categorized as underweight (<18.5 kg/m2), normal (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2), and obese (≥30 kg/m2). Maternal diabetes classified as no diabetes, type 1 (T1DM), type 2/other (T2DM), and gestational diabetes (GDM).Main Outcomes and Measures Odds ratio (OR) of isolated CHD in the child. In addition, nine anatomical CHD subgroups were studied.Results Of the 620 751 children born in Finland during the study period, 10 254 (1.65%) had an isolated CHD. T1DM was associated with an increased risk of having a child with any CHD (OR 3.71 (95% CI 3.16–4.35)), whereas maternal overweight (OR 0.98 (95% CI 0.98–1.04)) and obesity (OR 1.00 (95% CI 0.93–1.07)) were not. When analyzing anatomical subgroups, T1DM was associated with an increased risk in six subgroups. Maternal overweight was associated with complex defects (OR 2.24 (95% CI 1.01–4.94)), left ventricular outflow tract obstruction (OR 1.26, (95% CI 1.07–1.49), maternal obesity with complex defects (OR 3.22 (95% CI 1.31–7.92)), and right ventricular outflow tract obstruction (OR 1.26, (95% CI 1.01–1.55)). At the population level, maternal diabetes was responsible for 3.0% and maternal overweight and obesity for 0.7% of offspring’s CHD.Conclusions and Relevance This study indicated a less profound association between maternal overweight and obesity and CHD in the offspring than previously reported. The different risk profiles of T1DM and overweight/obesity may suggest distinct underlying teratogenic mechanisms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by: Academy of Finland (331405) and (315690 NORDCAP), Finnish Medical Foundation, Finnish Foundation for Pediatric Research, Finnish Foundation for Cardiovascular Research, European Commission (733280 RECAP Research on Children and Adults Born Preterm), Sigrid Juselius Foundation, Signe and Ane Gyllenberg Foundation, Yrjo Jahnsson Foundation, Novo Nordisk Foundation, Finnish Diabetes Research Foundation. This study was also supported by European Commission through Horizon 2020 (874739) and Horizon Europe (101057739).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the Finnish Institute for Health and Welfare gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccording to Finnish legislation researchers working outside the statutory register authority Finnish Institute for Health and Welfare can access register data for research purposes by applying for permission from the Finnish Social and Health Data Permit Authority Findata (findata.fi/en)